A RETROSPECTIVE cohort study in a 'real-world' setting has revealed that switching patients between generic equivalents may expose patients to a higher risk of therapy discontinuation.
CLICK HERE for the BMJ absract.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Nov 16
